Headlines about Proto Labs (NYSE:PRLB) have been trending somewhat positive on Sunday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Proto Labs earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news headlines about the industrial products company an impact score of 45.8176148102644 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Separately, Zacks Investment Research upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $137.00 target price on the stock in a research note on Friday, August 3rd. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $104.33.

Shares of NYSE:PRLB opened at $155.05 on Friday. Proto Labs has a twelve month low of $71.50 and a twelve month high of $156.52. The company has a market capitalization of $4.19 billion, a PE ratio of 80.34, a price-to-earnings-growth ratio of 2.93 and a beta of 1.22.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings data on Thursday, July 26th. The industrial products company reported $0.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.01. Proto Labs had a net margin of 15.98% and a return on equity of 13.55%. The firm had revenue of $109.65 million for the quarter, compared to analysts’ expectations of $110.46 million. During the same quarter in the prior year, the business earned $0.49 EPS. The business’s quarterly revenue was up 33.7% on a year-over-year basis. research analysts expect that Proto Labs will post 2.65 earnings per share for the current fiscal year.

In other news, CFO John Way sold 3,912 shares of the stock in a transaction that occurred on Friday, August 24th. The shares were sold at an average price of $145.79, for a total value of $570,330.48. Following the transaction, the chief financial officer now owns 29,415 shares in the company, valued at approximately $4,288,412.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John B. Goodman sold 1,113 shares of the stock in a transaction that occurred on Thursday, June 14th. The stock was sold at an average price of $131.50, for a total transaction of $146,359.50. Following the completion of the transaction, the director now owns 12,655 shares in the company, valued at approximately $1,664,132.50. The disclosure for this sale can be found here. Insiders sold a total of 18,457 shares of company stock worth $2,612,722 in the last quarter. Company insiders own 0.64% of the company’s stock.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.

See Also: The Role of a Fiduciary and Individual Investors

Insider Buying and Selling by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.